Profiles of Circulating MiRNAs Following Metformin Treatment in Patients with Type 2 Diabetes

BACKGROUND: Metformin, a widely used biguanide class of anti–diabetic drug, has potential to increase insulin sensitivity and reduce blood glucose to treat type 2 diabetes (T2D). It has been reported that metformin has an activity on regulation of miRNAs by targeting several downstream genes in meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirsoy, İbrahim Halil, Ertural, Duygu Yolal, Balci, Şenay, Çınkır, Ümit, Sezer, Kerem, Tamer, Lülüfer, Aras, Nurcan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298473/
https://www.ncbi.nlm.nih.gov/pubmed/30584410
http://dx.doi.org/10.2478/jomb-2018-0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298473/
https://www.ncbi.nlm.nih.gov/pubmed/30584410
http://dx.doi.org/10.2478/jomb-2018-0009

Ejemplares similares